Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYSanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposisPREV STORYOSE Immunotherapeutics Announces Results of 2019 Annual Shareholder Meeting